Unexplained Leukocytosis, Thrombocytosis in MPNs Warrants Evaluation for CML

A chart review of patients with myeloproliferative neoplasms (MPNs) who developed unexplained leukocytosis or thrombocytosis demonstrated that these patients should be evaluated for chronic myelogenous leukemia (CML), according to a case series described at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting. 

 Oncol Nurse Adv

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.